Adaptive designs allow modifications to clinical trials as they are ongoing based on accumulating data without undermining validity. This speeds learning and application of knowledge while maintaining scientific standards. Key benefits include faster drug development and efficient use of resources, though statistical complexity is increased. Sample size re-estimation and seamless phase II/III designs are two applications that maintain rigor while adding flexibility.